These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 264604)

  • 21. Antagonistic effect of somatostatin on corticotropin-releasing factor-induced anorexia in the rat.
    Shibasaki T; Kim YS; Yamauchi N; Masuda A; Imaki T; Hotta M; Demura H; Wakabayashi I; Ling N; Shizume K
    Life Sci; 1988; 42(3):329-34. PubMed ID: 2892109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral depression: thyroid interactions with norepinephrine-depleting drugs.
    Davenport JW; Hennies RS; Carey JC; Bishop SB
    Pharmacol Biochem Behav; 1976 Jul; 5(1):87-9. PubMed ID: 186817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anorexia and urinary zinc excretion after administration of L-histadine in humans.
    Henkin RI
    Am J Clin Nutr; 1980 Mar; 33(3):540-1. PubMed ID: 6928339
    [No Abstract]   [Full Text] [Related]  

  • 24. Behavioural structure and mechanisms of anorexia: calibration of natural and abnormal inhibition of eating.
    Blundell JE; Rogers PJ; Hill AJ
    Brain Res Bull; 1985 Oct; 15(4):371-6. PubMed ID: 2998562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of brain norepinephrine in neuroleptic-induced catalepsy in rats.
    Honma T; Fukushima H
    Pharmacol Biochem Behav; 1977 Dec; 7(6):501-6. PubMed ID: 201939
    [No Abstract]   [Full Text] [Related]  

  • 26. On the central noradrenergic mechanism involved in haloperidol-induced catalepsy in the rat.
    Al-Shabibi UM; Doggett NS
    J Pharm Pharmacol; 1978 Aug; 30(8):529-31. PubMed ID: 28412
    [No Abstract]   [Full Text] [Related]  

  • 27. Anorexia and hyperphagia produced by five pharmacologic classes of hallucinogens.
    Vaupel DB; Morton EC
    Pharmacol Biochem Behav; 1982 Sep; 17(3):539-45. PubMed ID: 6292959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal symptoms of digoxin toxicity.
    Holt DW; Volans GN
    Br Med J; 1977 Sep; 2(6088):704. PubMed ID: 268993
    [No Abstract]   [Full Text] [Related]  

  • 29. Apomorphine anorexia: a behavioural and neuropharmacological analysis.
    Willner P; Towell A; Muscat R
    Psychopharmacology (Berl); 1985; 87(3):351-6. PubMed ID: 3936092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity.
    Dolphin A; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Oct; 5(4):431-9. PubMed ID: 1005491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anorexia induced in rat by D-glucosamine deoxidized at C-1.
    Fujimoto K; Sakata T; Shiraishi T; Kurata K; Terada K; Etou H
    Am J Physiol; 1986 Sep; 251(3 Pt 2):R481-91. PubMed ID: 3463216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioural microanalysis of the role of dopamine in amphetamine anorexia.
    Towell A; Muscat R; Willner P
    Pharmacol Biochem Behav; 1988 Jul; 30(3):641-8. PubMed ID: 3211973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothermic effect of dopamine and L-DOPA in the domestic fowl (Gallus domesticus).
    Wambebe C; Osuide G
    Gen Pharmacol; 1981; 12(5):335-8. PubMed ID: 7286601
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of inhibitors of the catecholamine synthesis on motor activity in the rat during light and darkness.
    Berger T; Lemmer B
    Pol J Pharmacol Pharm; 1976; 28(6):601-3. PubMed ID: 1012983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of some CNS depressants on the hypermotility and anorexia induced by amphetamine in rats.
    Borella LE; Paquette R; Herr F
    Can J Physiol Pharmacol; 1969 Oct; 47(10):841-7. PubMed ID: 5259591
    [No Abstract]   [Full Text] [Related]  

  • 36. Is the release of noradrenaline necessary for self-stimulation of the brain?
    Shaw SG; Rolls ET
    Pharmacol Biochem Behav; 1976 Apr; 4(4):375-9. PubMed ID: 935209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-aggressive action of dopamine-beta-hydroxylase inhibitors in mice.
    Ross SB; Ogren SO
    J Pharm Pharmacol; 1976 Jul; 28(7):590-2. PubMed ID: 8618
    [No Abstract]   [Full Text] [Related]  

  • 38. Alpha-methyldopamine as a dopaminergic agonist.
    Duvoisin RC; Marsden CD
    Adv Neurol; 1975; 9():243-8. PubMed ID: 1146655
    [No Abstract]   [Full Text] [Related]  

  • 39. Differences in the content and turnover of noradrenaline in rat heart atria and ventricles and circadian-phase-dependency.
    Lemmer B; Weimer R
    Experientia; 1983 Sep; 39(9):998-1000. PubMed ID: 6884497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anorexic effects of naltrexone in man.
    Sternbach HA; Annitto W; Pottash AL; Gold MS
    Lancet; 1982 Feb; 1(8268):388-9. PubMed ID: 6120359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.